Bone Marrow Transplant in Oncology. Source Pathology  Treat Leukemia by chemotherapy  Regeneration of normal marrow  Chemotherapy alone cannot eliminate.

Slides:



Advertisements
Similar presentations
Hematopoietic Stem Cell Transplantation Lynn Savoie September 30, 2006.
Advertisements

Cancer 101 Monica Schlatter, RN, ND, AOCNP. Types of Cancer AIDS- related malignancies AIDS- related malignancies Bone and soft tissue sarcoma Bone and.
A Project on Bone marrow HASEEB TANVEER/ FOZIA TANVEER
A single centre study of the efficacy of extracorporeal photopheresis in Acute Graft Versus Host Disease Lynne Watson Nottingham University Hospital NHS.
Bone Marrow Transplant in Oncology
Questions and Answers about Bone Marrow Stem Cell Transplantation prepared by the Armenian Bone Marrow Donor Registry.
Blood and Marrow Transplant: The basics…what you need to know Resident Education Lecture Series.
Hematopoietic stem cell transplantation
BLOOD TRANSFUSION SUPPORT IN STEM CELL TRANSPLANT
Blood and marrow stem cell transplantation A.Basi ADULT HEMATOLOGIST,ONCOLOGIST IRAN UNIVERSITY OF MEDICAL SCIENCES.
Hematopoietic Stem Cell Transplantation (HSCT) Overview Willis H Navarro, MD Medical Director, Transplant Services, NMDP Associate Clinical Professor,
Bone Marrow Transplantation. Unlike solid organ transplant, in bone marrow transplantation (BMT) the immunology goes two ways. There is host vs. ​ graft.
Transplantation of hematopoietic stem cells in pediatric oncology Vladivostok State Medical University Foreign languages department Vladivostok 2012 Scientific.
Transplantation Autologous Syngeneic Allogeneic Xenogeneic.
Jeffrey Schriber, M.D. FRCP (c) Medical Director Cancer Transplant Institute Virginia G. Piper Cancer Center Everything You Ever Wanted to Know About Transplant.
TREATMENTS Surgical Oncology Chemotherapy Radiation Therapy Bone Marrow Transplant Complementary Medicine Psychotherapy.
Transplantation Immunology Laura Stacy March 22, 2006.
Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2010 CIBMTR Summary Slides SUM10_1.ppt.
Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2011 Summary Slides Worldwide SUM-WW11_1.ppt.
Building Canada’s National Public Cord Blood Bank.
Introduction to Haematopoietic Stem Cell Transplantation (HSCT) Covenant Health System HSCT Program Lubbock, Texas April 4, 2007.
Bone Marrow Transplantation The transfer of living cells, tissues, or organs from a donor to a recipient, with the.
Sami Sasala Brooke McVay Tiffany Vandiver
Supplementary Table 1. Impact of pretransplant factors on the incidence of pulmonary complications FactorUnivariate RR (95% CI)P-valueMultivariate RR *1.
DONOR LYMPHOCYTE INFUS I ON (DLI) Dr. Serdar ŞIVGIN February 2011 Kayseri.
Reduced-Intensity Conditioning (RIC) and Allogeneic Stem Cell Transplantation (allo-SCT) for Relapsed/Refractory Hodgkin Lymphoma (HL) in the Brentuximab.
Immunology of transplantation. Types of transplantation Autotransplantation –within one organism Allotransplantation- between one species Xenotransplantation-
STEM CELLS – ETHICAL ISSUES National 4 & 5 Biology – multicellular organisms.
Bone marrow Transplant in Paediatric Haematology
Chronic myeloid leukaemia Cancer of granulocyte production Too many (non functioning) granulocytes are produced Bone marrow is overcrowded with ineffective.
TRANSPLANTATION & tissue rejection
Meet Emaleigh Marlene Bosch Hello, I am pleased to introduce you to Emaleigh Marlene Bosch, she is 9 years old, almost 10. It is her Birthday on the 24th.
BLOOD DISORDERS.
Table 1.1.1: Stock and Flow of Blood and Marrow Transplantation, Year New transplant patients Deaths
HAEMATOPOIETIC STEM ELL TRANSPLANTATION (HSCT) A process in which abnormal, malignant, or non- functioning marrow cells are replaced with normal marrow.
(A) the hematopoietic stem cell transplanted (HSCT) recipients only (B) both autologous and allogeneic transplanted recipients (C) both solid organ and.
Blood Types A B AB O. Four major types of blood. A, B, AB, and O. Inherited from parents. Determined by presence or absence of an ANTIGEN on the surface.
Bone Marrow Donation. What is Bone marrow?  flexible spongy tissue in the interior of bones such as your hip and thigh.  constitutes 4% of the total.
HAPLOIDENTICAL STEM CELL TRANSPLANT
Hematopoietic Stem Cell Transplantation (HSCT)
HAEMATOPOIETIC STEM ELL TRANSPLANTATION (HSCT) A process in which abnormal, malignant, or non- functioning marrow cells are replaced with normal marrow.
New Approaches for Transplant Patients Linda J Burns, MD Medical Director, Health Services Research Program National Marrow Donor Program (NMDP)/Be the.
Bone Marrow Transplant
Blood and Marrow Transplant: The basics…what you need to know
By : Raffi , Manal , Shayla , Luana & Abhi
Stem Cell Transplantation
Treatment of Aplastic Anemia
Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation
GVHD-Like Colitis in Renal Graft Recipient
Tissue and Organ Transplantation
Transplantation Pathology
Supplemental table 1 Patients' characteristics Variables Number
Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation
Current Uses and Outcomes of Hematopoietic Cell Transplantation (HCT)
Human Health and Disease
Human Health and Disease
EBMT Activity Survey Teams 39,313 Patients 43,636 Transplants
LEUKEMIA By: J.U..
EBMT Activity Survey Teams Patients Transplants
Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Allogeneic Hematopoietic Cell Transplantation: Prognostic Relevance of the Initial.
Transplantation Immunology
by Jayesh Mehta Blood Volume 112(2): July 15, 2008
Stem Cells and Cellular Differentiation
ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION for MULTIPLE MYELOMA
Transplantation Rejection of foreign tissue grafts is due to immune responses to alloantigens on the graft Blood group antigens Polymorphic MHC antigens.
Table 1.1.1: Stock and Flow of Blood and Marrow Transplantation,
Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Allogeneic Hematopoietic Cell Transplantation: Prognostic Relevance of the Initial.
Transplantation Immunology
Introduction. Title: Activities and Outcomes of Hematopoietic Cell Transplantation in Japan.
Clinical Lymphoma, Myeloma and Leukemia
Presentation transcript:

Bone Marrow Transplant in Oncology

Source

Pathology  Treat Leukemia by chemotherapy  Regeneration of normal marrow  Chemotherapy alone cannot eliminate all malignant cells  Stem cell transplants.

Tranplant  Patient's bone marrow stem cells are replaced with healthy cells  Existing bone marrow and abnormal leukocytes killed  Chemotherapy and radiation  Next bone marrow containing healthy stem cells re-infused

Adult Stem Cell Transplant

Procedure  Most blood stem cells reside in the bone marrow and a small number are present in the bloodstream  Multipotent peripheral blood stem cells  Can be obtained from drawn blood  PBSCs are easier to collect than bone marrow stem cells

Harvesting

Transplantation  Autologous  Allogeneic  Syngeneic

Indications  Hematological diseases Benign : Thallassaemia, Aplastic Anaemia Malignant : Leukemia Lymphoma Myeloma  Immune deficiency disorders Pediatric and Adult  Neurological Disease (MS)

Auto Transplant

Allotransplant

Who can be the donor Bone marrow donors can be any normal person who is willing to donate. Even the comatose patient can be donor. Donor can not be the cadaver. Preferable if siblings or parents can donate. This is done just prior to time of transplant

Graft Verses Host Disease (GVHD)  GVHD sometimes occurs with allogeneic transplantation.  Lymphocytes from the donor graft attack the cells of the host  GVHD can usually be treated with steroids or other immunosuppressive agents.  Acute GVHD occurs before day 100 post-transplant  Chronic GVHD occurs beyond day 100  Recent advances have reduced the incidence and severity of this post-transplant complication, but GVHD, directly or indirectly, still accounts for approximately 15% of deaths in stem cell transplant patients  Chronic GVHD can develop months or even years post-transplant

GVHD  Skin/Hair Rash, scleroderma, lichenoid skin changes, dyspigmentation,alopecia  Eyes Dryness, abnormal Schirmer's Test, cornealerosions, conjunctivitis  Mouth Atrophic changes, lichenoid changes, mucositis,ulcers, xerostomia, dental caries  Lungs Bronchiolitis obliterans  GI tract Esophageal involvement, chronic nausea/vomiting, chronic diarrhea, malabsorption, fibrosis, abdomina l pain/cramps  Liver Abnormal LFTs, biopsy abnormalities  Genitourinary Vaginitis, strictures, stenosis, cystitis  Musculoskeletal Arthritis, contractures, myositis, myasthenia, fascities  Hematologic Thrombocytopenia, eosinophilia, autoantibodies